Characterization of LGALS3 (galectin-3) as a player in DNA damage response (2014)
- Authors:
- USP affiliated authors: MORALES, ANDRESSA GOIS - IB ; OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidades: IB; FMRP
- DOI: 10.4161/cbt.28873
- Subjects: CULTURA DE CÉLULAS (TENDÊNCIAS); NEOPLASIAS (ETIOLOGIA); DANO AO DNA
- Language: Inglês
- Imprenta:
- Publisher place: Georgetown
- Date published: 2014
- Source:
- Título do periódico: Cancer Biology and Therapy
- ISSN: 1538-4047
- Volume/Número/Paginação/Ano: v. 15, n. 7, p. 840-850, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
CARVALHO, Renato S. et al. Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biology and Therapy, v. 15, n. 7, p. 840-850, 2014Tradução . . Disponível em: https://doi.org/10.4161/cbt.28873. Acesso em: 19 abr. 2024. -
APA
Carvalho, R. S., Fernandes, V. C., Nepomuceno, T. C., Rodrigues, D. C., Woods, N. T., Suarez-Kurtz, G., et al. (2014). Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biology and Therapy, 15( 7), 840-850. doi:10.4161/cbt.28873 -
NLM
Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA. Characterization of LGALS3 (galectin-3) as a player in DNA damage response [Internet]. Cancer Biology and Therapy. 2014 ; 15( 7): 840-850.[citado 2024 abr. 19 ] Available from: https://doi.org/10.4161/cbt.28873 -
Vancouver
Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA. Characterization of LGALS3 (galectin-3) as a player in DNA damage response [Internet]. Cancer Biology and Therapy. 2014 ; 15( 7): 840-850.[citado 2024 abr. 19 ] Available from: https://doi.org/10.4161/cbt.28873 - Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation
- Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells
- In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors
- MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells
- Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro
- Inhibition of NF-'capa'B by dehydroxymethylepoxyquinomicin suppresses invasion and synergistically potentiates temozolomide and 'gama'-radiation cytotoxicity in glioblastoma cells
- Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells
- Effects of polo-like kinase 1 inhibition on glioblastoma cell lines
- BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity
- PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia
Informações sobre o DOI: 10.4161/cbt.28873 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
